Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;7(5):R661-8.
doi: 10.1186/bcr1261. Epub 2005 Jun 14.

Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells

Affiliations

Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells

Kristina A Szabo et al. Breast Cancer Res. 2005.

Abstract

Introduction: The presence of monocyte and macrophage cells in growing breast tumors, and the positive relationship between the degree of immune cell infiltration and tumor growth, suggest a possible paracrine growth regulatory function of immune cells in breast cancer.

Method: To better understand the interaction between monocytes and breast cancer cells, in vitro matrix metalloproteinase and tissue inhibitor of metalloproteinase activity was assessed from the THP-1 myeloid cell line in response to conditioned media from two breast cancer cell lines, MCF-7 and MDA-MB-231.

Results: Enzymography and immunoblotting revealed increased MMP-2 as well as increased levels of TIMP-1 and TIMP-2. Furthermore, a significant increase in the invasive potential of MCF-7 and MDA-MB-231 cells was noted in response to THP-1 cell-conditioned media.

Conclusion: These data demonstrate that monocyte cells in the breast tumor microenvironment play an important role in the modulation of MMPs, which may have a significant effect on the control of tumor growth and metastatic spread.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The effects of MCF-7 breast adenocarcinoma CM on MMP and TIMP activity from THP-1 monocytes. (a) Gelatin zymogram and (b) MMP-2 immunoblot showing the upregulation of monocyte MMP-2 after exposure to MCF-7 CM, and (c) a reverse zymogram to show that the activity of monocyte TIMP-1 and -2 remained the same upon treatment. Lanes 1, 4, and 7 contain CM from THP-1 cells in serum-free media grown in the presence of 100 μl, 200 μl and 300 μl concentrated MCF-7 CM, respectively. Lanes 2, 5, and 8 contain CM from THP-1 cells in serum-free media grown in the presence of 100 μl, 200 μl and 300 μl concentrated serum-free media, respectively. Lanes 3, 6, and 9 contain serum-free media with 100 μl, 200 μl and 300 μl, respectively, of MCF-7 CM in the absence of THP-1 cells. These figures are representative of three independent experiments carried out in duplicate, each of which demonstrates similar results.
Figure 2
Figure 2
The effects of MDA-MB-231 breast adenocarcinoma CM on MMP and TIMP activity from THP-1 monocytes. (a) Gelatin zymogram and (b) MMP-2 immunoblot showing the upregulation of monocyte MMP-2 after exposure to MDA-MB-231 CM, and (c) a reverse zymogram to show that the activity of monocyte TIMP-2 was also upregulated upon exposure to MDA-MB-231 CM, although TIMP-1 activity remained the same upon treatment. Lanes 1, 4, and 7 contain CM from THP-1 cells in serum-free media grown in the presence of 100 μl, 200 μl and 300 μl concentrated MDA-MB-231 CM, respectively. Lanes 2, 5, and 8 contain CM from THP-1 cells in serum-free media grown in the presence of 100 μl, 200 μl and 300 μl concentrated serum-free media, respectively. Lanes 3, 6, and 9 contain serum-free media with 100 μl, 200 μl and 300 μl, respectively, of MDA-MB-231 CM in the absence of THP-1 cells. These figures are representative of three independent experiments carried out in duplicate, each of which demonstrates similar results.
Figure 3
Figure 3
MCF-7 and MDA-MB-231 upregulation of TIMP-1 and TIMP-2 protein levels from THP-1 monocytes. Immunoblots representative of three independent experiments carried out in duplicate using monoclonal (a,b) TIMP-1 and (c,d) TIMP-2 antibodies to show an increased production of both proteins by monocyte cells in response to MCF-7 and MDA-MB-231 CM. Lane 1 contains CM from THP-1 cells in serum-free media grown in the presence of 300 μl concentrated (a,c) MCF-7 CM and (b,d) MDA-MB-231 CM. Lane 2 contains CM from THP-1 cells in serum-free media grown in the presence of 300 μl concentrated serum-free media. Lane 3 contains serum-free media with 300 μl of (a,c) MCF-7 CM and (b,d) MDA-MB-231 CM in the absence of THP-1 cells. Lane 4 contains unconcentrated (a) MCF-7 and (b,d) MDA-MB-231 CM.
Figure 4
Figure 4
The effects of monocyte cells and CM on the invasive potential of breast adenocarcinoma cells. Graphs showing an increase in the number of (a) MCF-7 and (b) MDA-MB-231 cells that migrated through matrigel-coated membranes in response to monocyte cell CM. The following conditions were used in the lower chamber: 1, serum-free media; 2, 10% FBS in serum-free media; 3, THP-1 cell-conditioned media; 4, (a) 5 × 104 MCF-7 cells, (b) 5 × 104 MDA-MB-231 cells; 5, 5 × 104 THP-1 cells; 6, (a) 10 × 104 MCF-7 cells, (b) 10 × 104 MDA-MB-231 cells; 7, 10 × 104 THP-1 cells. *p < 0.05 compared to condition 2; **p < 0.05 compared to condition 4; ***p < 0.05 compared to condition 6. The values are the means of three experiments and the error bars are the standard error of the mean.

References

    1. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol. 1998;64:275–290. - PubMed
    1. Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res. 2001;23:263–272. doi: 10.1385/IR:23:2-3:263. - DOI - PubMed
    1. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–998. doi: 10.1038/ni1102-991. - DOI - PubMed
    1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. doi: 10.1016/S0140-6736(00)04046-0. - DOI - PubMed
    1. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis. 2002;19:247–258. doi: 10.1023/A:1015587423262. - DOI - PubMed

Publication types

Substances